During the past decade, Carolina Headache Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Headache Institute" #1 sponsor was "Allergan" with 2 trials, followed by "ElectroCore INC" with 2 trials sponsored, "Autonomic Technologies, Inc." with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Scion NeuroStim" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Carolina Headache Institute" are "Migraine, With or Without Aura" (2 trials), "Chronic Cluster Headache" (1 trials), "Chronic Migraine" (1 trials), "Cluster Headache" (1 trials) and "Migraine Headache, Episodic" (1 trials). Many other conditions were trialed in "Carolina Headache Institute" in a lesser frequency.

Most popular intervention types in "Carolina Headache Institute" are "Device" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ATI Neurostimulation System" (1 trials), "AVP-786" (1 trials), "Atogepant" (1 trials), "GammaCore" (1 trials) and "GammaCore Active Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Headache Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Carolina Headache Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Carolina Headache Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Headache Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".